186 related articles for article (PubMed ID: 24323634)
1. Solely abluminal drug release from coronary stents could possibly improve reendothelialization.
Zhang H; Deng W; Wang X; Wang S; Ge J; Toft E
Catheter Cardiovasc Interv; 2016 Sep; 88(3):E59-66. PubMed ID: 24323634
[TBL] [Abstract][Full Text] [Related]
2. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
3. In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter.
Obata JE; Nakamura T; Kitta Y; Saito Y; Sano K; Fujioka D; Kawabata K; Kugiyama K
Catheter Cardiovasc Interv; 2013 Nov; 82(6):E777-87. PubMed ID: 23378231
[TBL] [Abstract][Full Text] [Related]
4. Assessment of an asymmetrical coating stent with sirolimus released from ablumial matrix in porcine model.
Shen L; Wu Y; Zhang F; Wu L; Dong C; Gao Y; Sun A; Zou Y; Qian J; Sun J; Zhong W; Ge J
Clin Res Cardiol; 2012 Nov; 101(11):917-27. PubMed ID: 22627890
[TBL] [Abstract][Full Text] [Related]
5. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
[TBL] [Abstract][Full Text] [Related]
6. Late catch-up in lumen diameter at five-year angiography in MACE-free patients treated with sirolimus-eluting stents in the Primary Stenting of Totally Occluded Native Coronary Arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II).
Teeuwen K; Van den Branden BJ; Rahel BM; Laarman GJ; Tijssen JG; Kelder JC; Slagboom T; Ten Berg JM; Suttorp MJ
EuroIntervention; 2013 Jun; 9(2):212-9. PubMed ID: 23392450
[TBL] [Abstract][Full Text] [Related]
7. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
8. The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term.
Nasuno T; Tokura M; Kageyama M; Toyoda S; Sakuma M; Komatsu T; Taguchi I; Abe S; Inoue T
Heart Vessels; 2016 Jun; 31(6):985-9. PubMed ID: 25939630
[TBL] [Abstract][Full Text] [Related]
9. A head to head comparison of XINSORB bioresorbable sirolimus-eluting scaffold versus metallic sirolimus-eluting stent: 180 days follow-up in a porcine model.
Shen L; Wu Y; Ge L; Zhang Y; Wang Q; Qian J; Qiu Z; Ge J
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1473-1481. PubMed ID: 28639098
[TBL] [Abstract][Full Text] [Related]
10. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
[TBL] [Abstract][Full Text] [Related]
11. Polymer-free dual drug-eluting stents evaluated in a porcine model.
Zhang B; Zheng B; Wang X; Shi Q; Jia J; Huo Y; Pan C; Han J; Chen M
BMC Cardiovasc Disord; 2017 Aug; 17(1):222. PubMed ID: 28810900
[TBL] [Abstract][Full Text] [Related]
12. Effects of local intracoronary paclitaxel delivery using the Remedy transport catheter on neointimal hyperplasia after stent implantation in a porcine model.
Milewski K; Zurakowski A; Pajak J; Liszka L; Debinski M; Buszman PP; Samra MA; Dominek P; Aboodi MS; Kaluza GL; Buszman P
Cardiovasc Revasc Med; 2011; 12(2):82-9. PubMed ID: 21421185
[TBL] [Abstract][Full Text] [Related]
13. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
14. Vascular responses to a biodegradable polymer (polylactic acid) based biolimus A9-eluting stent in porcine models.
Hagiwara H; Hiraishi Y; Terao H; Hirai T; Sakaoka A; Sasaki M; Murota S; Inoue K; Kimura J
EuroIntervention; 2012 Oct; 8(6):743-51. PubMed ID: 23086793
[TBL] [Abstract][Full Text] [Related]
15. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
[TBL] [Abstract][Full Text] [Related]
16. Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries.
Milewski K; Gorycki B; Buszman PP; Jelonek M; Beaudry D; Lapointe JM; Guy LG; Abusamra M; Pająk J; Kinasz W; Wojakowski W; Leclerc G; Gil RJ; Buszman PE
Kardiol Pol; 2012; 70(7):703-11. PubMed ID: 22825946
[TBL] [Abstract][Full Text] [Related]
17. Head-to-head comparison of sirolimus-eluting stent versus bare metal stent evaluation of the coronary endothelial dysfunction in the same patient presenting with multiple coronary artery lesions: the CREDENTIAL study.
Mischie AN; Nazzaro MS; Fiorilli R; De Felice F; Musto C; Confessore P; Parma A; Boschetti C; Violini R
Catheter Cardiovasc Interv; 2013 Sep; 82(3):E184-91. PubMed ID: 23359371
[TBL] [Abstract][Full Text] [Related]
18. Biological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug eluting stent restenosis swine model.
Li Y; Tellez A; Rousselle SD; Dillon KN; Garza JA; Barry C; Granada JF
Catheter Cardiovasc Interv; 2016 Jul; 88(1):89-98. PubMed ID: 26613810
[TBL] [Abstract][Full Text] [Related]
19. Succinobucol-eluting stents increase neointimal thickening and peri-strut inflammation in a porcine coronary model.
Watt J; Kennedy S; McCormick C; Agbani EO; McPhaden A; Mullen A; Czudaj P; Behnisch B; Wadsworth RM; Oldroyd KG
Catheter Cardiovasc Interv; 2013 Mar; 81(4):698-708. PubMed ID: 22581717
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a novel slow-release paclitaxel-eluting stent with a bioabsorbable polymeric surface coating.
Jabara R; Chronos N; Conway D; Molema W; Robinson K
JACC Cardiovasc Interv; 2008 Feb; 1(1):81-7. PubMed ID: 19393150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
